Avalon Globocare (ALBT)

Mar 12, 2025, 7:15 PM EDT - 6 weeks ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates JWN and ALBT on Behalf of Shareholders

JWN

Nov 18, 2024, 9:00 AM EST - 5 months ago

Avalon GloboCare Launches “BrAce for Impact" Affiliate Marketing Program for the KetoAir Breathalyzer Device

Oct 25, 2024, 9:00 AM EDT - 6 months ago

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Jul 31, 2024, 8:00 AM EDT - 9 months ago

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

May 24, 2024, 5:00 PM EDT - 1 year ago

Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report

Apr 22, 2024, 9:00 AM EDT - 1 year ago

Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference

Mar 28, 2024, 9:00 AM EDT - 1 year ago

Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European Union

Dec 18, 2023, 9:00 AM EST - 1 year ago

Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the US

Oct 4, 2023, 9:00 AM EDT - 1 year ago

Apple Approves Use of Avalon GloboCare's KetoAir Mobile Application

Sep 13, 2023, 9:15 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

Aug 30, 2023, 9:00 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

Aug 21, 2023, 9:00 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Announces Expansion into Arizona

Jul 24, 2023, 9:00 AM EDT - 1 year ago

Avalon's Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

Jul 19, 2023, 9:00 AM EDT - 1 year ago

Avalon GloboCare's Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Jul 10, 2023, 9:00 AM EDT - 1 year ago

Avalon GloboCare Provides Update on New Commercial Strategy

Apr 27, 2023, 9:00 AM EDT - 2 years ago

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

Mar 3, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare to Participate in the 35th Annual Roth Conference

Feb 13, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company

Jan 17, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Announces Issuance of Key U.S. Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor Molecules

Jan 11, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Appoints Lourdes Felix, CEO of a Premier Addiction Treatment Company, to its Board of Directors

Jan 3, 2023, 9:00 AM EST - 2 years ago

Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology

Dec 14, 2022, 9:00 AM EST - 2 years ago

Avalon GloboCare Announces $4 Million Private Placement of Preferred Stock with the Company's Chairman which Converts at a Significant Premium to Market; Proceeds to Support Acquisition of Laboratory Services

Dec 12, 2022, 9:00 AM EST - 2 years ago

Avalon GloboCare Continues its U.S. Centric Strategy with a New Proposed Board Composition in Preparation for Acquisition of Laboratory Services MSO, LLC

Nov 9, 2022, 4:00 PM EST - 2 years ago

Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”